share_log

Co-Diagnostics Shares Are Trading Higher After the Company Announced It Performed an in Silico Analysis of the Co-Dx Logix Smart Mpox RUO Test to Evaluate the Possible Impact of Clade Ib Mpox on the Test. Results Showed That the Test Should Retain...

Benzinga ·  Sep 5 21:33

Co-Diagnostics Shares Are Trading Higher After the Company Announced It Performed an in Silico Analysis of the Co-Dx Logix Smart Mpox RUO Test to Evaluate the Possible Impact of Clade Ib Mpox on the Test. Results Showed That the Test Should Retain Full Reactivity Against Mpox Strains Circulating Over the Last Year, Including Clade 1b.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment